Please check your internet connection and try again.
# Daidzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains daidzein and genistein, which are soy isoflavones, and palmitoylethanolamide (PEA), an endogenous fatty acid amide. Their exact synergistic mechanisms are under investigation.
## Primary Indications
This combination is primarily used for its potential anti-inflammatory and analgesic properties. It may be considered for conditions involving chronic inflammation and pain.
## Adult Dosing
Specific dosing is not established by regulatory agencies. Common over-the-counter formulations vary widely. A typical daily dose observed in studies ranges from **200-800 mg of PEA** per day, often divided into two doses, with varying amounts of daidzein and genistein. Prescribing should be guided by available clinical evidence and patient response.
## Pediatric Dosing
No established pediatric dosing. Safety and efficacy have not been studied in pediatric populations.
## Dose Adjustments
No specific dose adjustments are recommended for hepatic or renal impairment due to lack of data.
## Contraindications
* Hypersensitivity to any component of the formulation.
* Pregnancy and breastfeeding: due to lack of safety data.
## Adverse Effects
Generally well-tolerated. Potential adverse effects may include gastrointestinal upset (nausea, diarrhea) and, rarely, allergic reactions.
## Key Drug Interactions
* **Hormone-sensitive conditions:** Isoflavones (daidzein, genistein) possess weak estrogenic activity. Caution is advised in patients with hormone-sensitive cancers (e.g., breast, ovarian, uterine) or a history thereof.
* **Anticoagulants/Antiplatelets:** Soy isoflavones may theoretically affect platelet aggregation. Monitor patients on these medications closely.
* **CYP450 substrates:** Limited data available; evaluate potential for interactions based on individual drug profiles.
## Monitoring
* Monitor for signs of allergic reaction.
* Assess for gastrointestinal distress.
* Evaluate for therapeutic efficacy in pain and inflammation management.
## Clinical Pearls
* This is a supplement and is not FDA-approved for any medical condition.
* Onset of action can be variable and may take several weeks.
* Quality and purity of over-the-counter products can vary significantly.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant literature before making any clinical decisions. Dosing and indications may vary based on product formulation and local guidelines.
